Concurrently, valsartan orchestrates multi-pathway regulation by targeting genetic networks involved in RAS hyperactivation, AGE-RAGE crosstalk, TGF-β signaling, and PI3K-Akt axis dysregulation, thereby mitigating renal fibrosis and tubular injury [155]. This evidence concerns the gene RENBP and renal fibrosis.